China Universal Asset Management Company’s Blueprint Medicines BPMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,971
Closed -$1.66M 484
2025
Q2
$1.66M Buy
12,971
+153
+1% +$15.9K 0.16% 123
2025
Q1
$1.13M Sell
12,818
-652
-5% -$63.6K 0.11% 171
2024
Q4
$1.17M Buy
13,470
+1,287
+11% +$118K 0.11% 140
2024
Q3
$1.13M Buy
12,183
+4,828
+66% +$480K 0.12% 130
2024
Q2
$793K Sell
7,355
-4,422
-38% -$443K 0.11% 119
2024
Q1
$1.12M Buy
11,777
+4,745
+67% +$407K 0.14% 120
2023
Q4
$649K Buy
7,032
+5,482
+354% +$355K 0.13% 130
2023
Q3
$77.8K Buy
1,550
+757
+95% +$40.5K 0.02% 208
2023
Q2
$50.1K Sell
793
-20
-2% -$1.09K 0.02% 190
2023
Q1
$36.6K Buy
813
+205
+34% +$9.23K 0.01% 175
2022
Q4
$26.6K Buy
608
+49
+9% +$2.35K 0.01% 159
2022
Q3
$37K Buy
+559
New +$35.9K 0.02% 130

Other funds holding BPMC

China Universal Asset Management Company's BPMC Position: Q3 2025 in Review

China Universal Asset Management Company sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 12,971 shares — an estimated $1.66M sold.

China Universal Asset Management Company first reported a position in BPMC in Q3 2022 and held it in 12 quarters. The position peaked at $1.66M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • China Universal Asset Management Company reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 12,971 Blueprint Medicines shares in Q3 2025, an estimated $1.66M.
  • China Universal Asset Management Company first reported a position in Blueprint Medicines in Q3 2022 and held it in 12 quarters.
  • China Universal Asset Management Company's Blueprint Medicines position peaked at $1.66M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.